We are live on
!
Find out more
HA
HHLR Advisors Portfolio holdings
AUM
$1.67B
1-Year Est. Return
7.53%
This Fund
S&P 500
This Quarter
Est. Return
+5.43%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$9.71B
AUM Growth
-$405M
(-4%)
Cap. Flow
-$603M
Cap. Flow
% of AUM
-6.21%
Top 10 Holdings %
Top 10 Hldgs %
61.24%
Holding
100
New
9
Increased
6
Reduced
17
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Airbnb
ABNB
|
+$331M |
| 2 |
Vipshop
VIPS
|
+$213M |
| 3 |
MINISO
MNSO
|
+$128M |
| 4 |
Alibaba
BABA
|
+$128M |
| 5 |
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
|
+$42.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$432M |
| 2 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$351M |
| 3 |
Zoom
ZM
|
+$316M |
| 4 |
GDS Holdings
GDS
|
+$214M |
| 5 |
APLS
Apellis Pharmaceuticals
APLS
|
+$84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.46% |
| 2 | Consumer Discretionary | 24.31% |
| 3 | Technology | 11.89% |
| 4 | Communication Services | 10.14% |
| 5 | Financials | 5.18% |
Similar funds
TFS
GC
PA
LCI
JPM
NRI
CPO
JIP
HHLR Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, HHLR Advisors held 100 positions worth $9.71B, down 4% from $10.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
HHLR Advisors withdrew a net $603M in Q2 2021, closing 11 positions and reducing 17 holdings. Its most notable exit was China Biologic Products Holdings, Inc., an estimated $351M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, HHLR Advisors opened a new position in Airbnb worth $324M.
- HHLR Advisors's largest Q2 2021 buy was Airbnb: 2,112,637 shares worth $324M.
- HHLR Advisors added most to Vipshop in Q2 2021, an estimated $213M increase.
- HHLR Advisors's biggest Q2 2021 reduction was Pinduoduo, cutting an estimated $432M.
- HHLR Advisors fully exited China Biologic Products Holdings, Inc. in Q2 2021, selling an estimated $351M.
- HHLR Advisors's ten largest holdings make up 61% of its $9.71B portfolio in Q2 2021.
- HHLR Advisors opened 9 new positions and closed 11 in Q2 2021.
- HHLR Advisors's portfolio value fell 4% quarter-over-quarter to $9.71B.
Based on HHLR Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.